- Home
- NAUT vs PTHL Comparison
NAUT vs PTHL Comparison
Compare NAUT & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- PTHL
- Stock Information
- Founded
- NAUT 2016
- PTHL 1998
- Country
- NAUT United States
- PTHL China
- Employees
- NAUT N/A
- PTHL N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- PTHL
- Sector
- NAUT Industrials
- PTHL
- Exchange
- NAUT Nasdaq
- PTHL Nasdaq
- Market Cap
- NAUT 91.5M
- PTHL 85.4M
- IPO Year
- NAUT N/A
- PTHL 2024
- Fundamental
- Price
- NAUT $0.69
- PTHL $17.85
- Analyst Decision
- NAUT Hold
- PTHL
- Analyst Count
- NAUT 2
- PTHL 0
- Target Price
- NAUT $3.88
- PTHL N/A
- AVG Volume (30 Days)
- NAUT 553.0K
- PTHL 1.1M
- Earning Date
- NAUT 07-29-2025
- PTHL 02-11-2025
- Dividend Yield
- NAUT N/A
- PTHL N/A
- EPS Growth
- NAUT N/A
- PTHL N/A
- EPS
- NAUT N/A
- PTHL N/A
- Revenue
- NAUT N/A
- PTHL $448,196.00
- Revenue This Year
- NAUT N/A
- PTHL N/A
- Revenue Next Year
- NAUT N/A
- PTHL N/A
- P/E Ratio
- NAUT N/A
- PTHL N/A
- Revenue Growth
- NAUT N/A
- PTHL N/A
- 52 Week Low
- NAUT $0.66
- PTHL $1.32
- 52 Week High
- NAUT $3.09
- PTHL $22.34
- Technical
- Relative Strength Index (RSI)
- NAUT 43.84
- PTHL N/A
- Support Level
- NAUT $0.69
- PTHL N/A
- Resistance Level
- NAUT $0.85
- PTHL N/A
- Average True Range (ATR)
- NAUT 0.06
- PTHL 0.00
- MACD
- NAUT 0.00
- PTHL 0.00
- Stochastic Oscillator
- NAUT 8.70
- PTHL 0.00
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.